COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2805: Articles 28041-28050  | Next

Machine learning model estimating number of COVID-19 infection cases over coming 24 days in every province of South Korea (XGBoost and MultiOutputRegressor)
Suzuki, Y., Suzuki, A.
10.1101/2020.05.10.20097527 — Posted: 2020-05-14
Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection
Ozturk, T., Howell, C., Benameur, K., Ramonell, R. P., Cashman, K., Pirmohammed, S., Bassit, L., Roback, J., Marconi, V. C., Schinazi, R. F., Wharton, W., Lee, F. E.-H., Hu, W. T.
10.1101/2020.05.10.20097535 — Posted: 2020-05-14
The far side of the COVID-19 epidemic curve: local re-openings based on globally coordinated triggers may work best
Karatayev, V., Anand, M., Bauch, C. T.
10.1101/2020.05.10.20097485 — Posted: 2020-05-14
Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?
Gumel, A. B., Iboi, E. A., Ngonghala, C. N.
10.1101/2020.05.10.20097428 — Posted: 2020-05-14
A rapid, point of care red blood cell agglutination assay for detecting antibodies against SARS-CoV-2
Kruse, R. L., Huang, Y., Smetana, H., Gehrie, E. A., Amukele, T. K., Tobian, A. A., Mostafa, H. H., Wang, Z. Z.
10.1101/2020.05.13.094490 — Posted: 2020-05-14 Discussion: Onsite | Offsite
Tracing two causative SNPs reveals SARS-CoV-2 transmission in North America population
Ou, X., Yang, Z., Zhu, D., Mao, S., Wang, M., Jia, R., Chen, S., Liu, M., Yang, Q., Wu, Y., Zhao, X., Zhang, S., Huang, J., Gao, Q., Liu, Y., Zhang, L., Peopplenbosch, M., Pan, Q., Cheng, A.-c.
10.1101/2020.05.12.092056 — Posted: 2020-05-14
Propagation, inactivation, and safety testing of SARS-CoV-2
Jureka, A. S., Silvas, J. A., Basler, C. F.
10.1101/2020.05.13.094482 — Posted: 2020-05-14
Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes
Guo, H., Hu, B., Yang, X., Zeng, L., Li, B., Ouyang, S., Shi, Z.
10.1101/2020.05.13.093658 — Posted: 2020-05-14
Defining the Pandemic at the State Level: Sequence-Based Epidemiology of the SARS-CoV-2 virus by the Arizona COVID-19 Genomics Union (ACGU)
Ladner, J. T., Larsen, B. B., Bowers, J. R., Hepp, C. M., Bolyen, E., Folkerts, M., Sheridan, K., Pfeiffer, A., Yaglom, H., Lemmer, D., Sahl, J. W., Kaelin, E. A., Maqsood, R., Bokulich, N. A., Quirk, G., Watt, T. D., Komatsu, K., Waddell, V., Lim, E. S., Caporaso, J. G., Engelthaler, D. M., Worobey, M., Keim, P.
10.1101/2020.05.08.20095935 — Posted: 2020-05-13
Structure of SARS-CoV-2 main protease in the apo state reveals the inactive conformation
Zhou, X., Zhong, F., Lin, C., Hu, X., Zhang, Y., Xiong, B., Yin, X., Fu, J., He, W., Duan, J., Fu, Y., Zhou, H., Wang, Q., Li, J., Zhang, J.
10.1101/2020.05.12.092171 — Posted: 2020-05-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).